SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following the company's announcement of a private exchange of debt for equity, a move sparking intense debate among investors regarding the balance sheet implications and potential future acquisition strategies. The community remains deeply divided, with many debating the impact of dilution versus the long-term benefit of reducing corporate debt as they look for signs of a potential squeeze or strategic shift.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investor sentiment strengthens around the company's growth trajectory and its flagship drug, Briumvi, which is on track to reach a significant annual revenue milestone. The community is actively discussing the stock's potential for a future acquisition by Big Pharma, especially as new trial data for indications like schizophrenia and Myasthenia Gravis fuels optimism about the long-term value of its pipeline.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is generating strong investor interest following a successful earnings beat driven by record store expansion and significant efficiency gains in delivery operations. Community discussion is heavily focused on the company's growth trajectory in China, the potential for a U.S. relisting, and the ongoing execution of its share repurchase program.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is surging following a strong quarterly report where record AWS growth and significant expansion in AI infrastructure demand alleviated concerns about heavy capital spending. The community is actively celebrating the breakout to 52-week highs, with many traders pivoting from semiconductors to hyperscalers as they track potential targets toward the 300 level.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is the subject of intense market attention as investors monitor an FDA Advisory Committee review of its lead candidate, RP1, for advanced melanoma. Community sentiment is deeply polarized between long-term holders betting on a positive outcome despite past regulatory hurdles, and skeptics who are anticipating a third Complete Response Letter due to concerns over trial design and data integrity.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors eagerly anticipate topline results from the Phase 3 IZAR-1 trial for sonelokimab, a key catalyst expected to demonstrate best-in-class efficacy in psoriatic arthritis. The community is actively debating the precise timing of this data release following management's recent guidance, while simultaneously weighing the potential for a significant M&A event given the stock's strong institutional backing and multi-indication pipeline.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is currently generating significant investor interest ahead of its earnings release, with community discussion centered on its expanding AI ecosystem, including partnerships with Palantir, OpenAI, and Snowflake. Investors are closely monitoring the stock's consolidation patterns and institutional accumulation, debating whether the company's recent AI-driven product advancements and strong growth metrics justify a significant re-rating.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is trending as investors react to reports of a potential mega-merger with AstraZeneca, sparking heavy trading volume and speculation regarding massive cost-cutting, structural synergies, and the company's long-term oncology strategy. The community remains focused on the deal's potential impact on headcount and the necessity of the tie-up to navigate significant looming patent cliffs.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending as it officially lists its ordinary shares on the NYSE, marking a significant transition to a more global investor base while navigating its massive strategic investment plan in China. Community discussion is focused on the stock's valuation, dividend potential, and the company's aggressive R&D pipeline that continues to draw interest as a diversified alternative to high-growth tech investments.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is experiencing heightened volatility as investors weigh the company's first quarterly earnings report against a massive upcoming share lockup expiration that could significantly increase tradable supply. The community remains deeply divided, with some betting on a short squeeze and long-term ecosystem growth, while others express concerns over the stock's valuation, insider selling pressure, and its status as an unprofitable growth play.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Which Aerospace and Defense ETF Is the Better Buy: State Street's XAR or First Trust's MISL?

Key PointsState Street SPDR S&P Aerospace & Defense ETF maintains a significantly higher AUM and a lower expense ratio than First Trust Indxx Aerospace & Defense ETF...

Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?

Key PointsState Street Health Care Select Sector SPDR ETF provides a much lower expense ratio of 0.08% compared to the 0.35% for State Street SPDR S&P Biotech ETF...

State Street to Expand Latam Presence With Santander CACEIS JV Buyout

STT is set to expand its Latin America footprint with the planned buyout of Santander CACEIS Latam Securities Services, adding scale across key regional markets.

State Street vs. First Trust: Is a Broad Healthcare or Biotech Focus Better for Your Portfolio?

Key PointsState Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio of 0.08% compared to the 0.55% charged by First Trust NYSE Arca Biotechnology Index Fund...

VNQI vs RWR: Which of These Real Estate ETFs Is the Better Buy in 2026?

Key PointsThe State Street SPDR Dow Jones REIT ETF (RWR) focuses exclusively on U.S. real estate investment trusts, while Vanguard Global ex-U.S. Real Estate ETF (VNQI) provides exposure to property markets in more than 30 countries outside the United States...

Leading And Lagging Sectors For July 28, 2026

Gainers

Symbol
Name
Price
Change ($)
Change (%)
Volume

(NYSE:XLP)
State Street Consumer Staples Select Sector SPDR ETF
86.9200
1.560
1.82
50.6K

(NYSE:XLV)
State Street Health Care Select Sector SPDRread more...

State Street to Expand Latin America Footprint with Santander CACEIS Latam Securities Services

State Street Corporation (NYSE: STT) today announced that it has signed an initial agreement to acquire the Santander CACEIS Latam Securities Services joint venture in Brazil, Mexico, and Colombia. The joint venture is owned by the Santander Group and CACEIS, with assets under custody (AUC) of...

XLV vs FHLC: Which Healthcare ETF Fits Your Portfolio?

Key PointsThe State Street Health Care Select Sector SPDR ETF manages $41.7 billion in assets under management (AUM), providing significantly higher liquidity than the Fidelity MSCI Health Care Index ETF...

Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?

Key PointsThe State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio and higher assets under management than the VanEck Pharmaceutical ETF...

How Do the Vanguard S&P 500 Growth ETF and the State Street Small Cap Growth ETF Compare?

Key PointsVanguard S&P 500 Growth ETF offers exposure to large-cap giants with a significantly lower expense ratio than the small-cap focused State Street fund...

State Street Corp. engages in the provision of financial services to institutional investors. It operates through the Commercial and Financial Loans, and Commercial Real Estate Loans segments. The company was founded in 1792 and is headquartered in Boston, MA.

State Street Corp.

BLK, STT In Focus — Who Will Manage New York City’s $92B Pension Portfolio?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$182.18
Prev Close	$184.16
Open	$183.43
Dividend Yield	2.48%
50-Day Moving Average	$171.32
Beta	1.02
Avg. Volume	2.48M
PE Ratio	16.24

52-Week High	$192.51
52-Week Low	$104.64
Market Capitalization	$50.59B
EPS (Annual)	$9.40
Price to Book	2.05
Revenue Per Employee	$419,470.71

Feed

News

Sentiment

Earnings

Fundamentals

Info